Omnicell Stock Current Valuation
| OMCL Stock | USD 45.96 0.27 0.59% |
Valuation analysis of Omnicell helps investors to measure Omnicell's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The value of Enterprise Value Over EBITDA is expected to slide to 22.21. The value of Enterprise Value Multiple is estimated to slide to 22.21. Fundamental drivers impacting Omnicell's valuation include:
Price Book 1.7186 | Enterprise Value 2.1 B | Enterprise Value Ebitda 38.464 | Price Sales 1.9885 | Forward PE 29.4985 |
Undervalued
Today
Please note that Omnicell's price fluctuation is very steady at this time. Calculation of the real value of Omnicell is based on 3 months time horizon. Increasing Omnicell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Omnicell stock is determined by what a typical buyer is willing to pay for full or partial control of Omnicell. Since Omnicell is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Omnicell Stock. However, Omnicell's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 45.96 | Real 53.92 | Target 66.43 | Hype 45.82 | Naive 40.45 |
The intrinsic value of Omnicell's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Omnicell's stock price.
Estimating the potential upside or downside of Omnicell helps investors to forecast how Omnicell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Omnicell more accurately as focusing exclusively on Omnicell's fundamentals will not take into account other important factors: Omnicell Company Current Valuation Analysis
Omnicell's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Omnicell Current Valuation | 2.15 B |
Most of Omnicell's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omnicell is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Omnicell Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Omnicell is extremely important. It helps to project a fair market value of Omnicell Stock properly, considering its historical fundamentals such as Current Valuation. Since Omnicell's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Omnicell's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Omnicell's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Omnicell has a Current Valuation of 2.15 B. This is 85.05% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 87.08% higher than that of the company.
Omnicell Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omnicell's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omnicell could also be used in its relative valuation, which is a method of valuing Omnicell by comparing valuation metrics of similar companies.Omnicell is currently under evaluation in current valuation category among its peers.
Omnicell ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Omnicell's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Omnicell's managers, analysts, and investors.Environmental | Governance | Social |
Omnicell Fundamentals
| Return On Equity | -0.0146 | ||||
| Return On Asset | -0.0087 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 2.15 B | ||||
| Shares Outstanding | 46.32 M | ||||
| Shares Owned By Insiders | 1.67 % | ||||
| Shares Owned By Institutions | 98.33 % | ||||
| Number Of Shares Shorted | 1.65 M | ||||
| Price To Earning | 64.95 X | ||||
| Price To Book | 1.72 X | ||||
| Price To Sales | 1.99 X | ||||
| Revenue | 1.15 B | ||||
| Gross Profit | 596.71 M | ||||
| EBITDA | (34.87 M) | ||||
| Net Income | (20.37 M) | ||||
| Cash And Equivalents | 244.95 M | ||||
| Cash Per Share | 5.53 X | ||||
| Total Debt | 614.09 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.11 X | ||||
| Book Value Per Share | 26.59 X | ||||
| Cash Flow From Operations | 181.09 M | ||||
| Short Ratio | 3.52 X | ||||
| Earnings Per Share | (0.39) X | ||||
| Price To Earnings To Growth | 2.28 X | ||||
| Target Price | 56.5 | ||||
| Number Of Employees | 3.66 K | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 2.12 B | ||||
| Total Asset | 2.23 B | ||||
| Retained Earnings | 370.36 M | ||||
| Working Capital | 559.78 M | ||||
| Current Asset | 50.15 M | ||||
| Current Liabilities | 50.17 M | ||||
| Net Asset | 2.23 B |
About Omnicell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Omnicell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omnicell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omnicell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Omnicell Piotroski F Score and Omnicell Altman Z Score analysis. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.558 | Earnings Share (0.39) | Revenue Per Share 23.218 | Quarterly Revenue Growth (0.05) | Return On Assets (0.01) |
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.